Philip Astley Sparke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philip astley sparke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philip Astley Sparke Today - Breaking & Trending Today

Leerink Partnrs Weighs in on Replimune Group, Inc.'s Q1 2025 Earnings (NASDAQ:REPL)

Replimune Group, Inc. (NASDAQ:REPL – Free Report) – Research analysts at Leerink Partnrs dropped their Q1 2025 earnings estimates for shares of Replimune Group in a research report issued on Thursday, May 16th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($0.85) per share for the quarter, down from their previous […] ....

Robert Coffin , Leerink Partnrs , Philip Astley Sparke , China Universal Asset Management Co , Tower Research Capital , Replimune Group , Quest Partners , Securities Exchange Commission , Replimune Group Price Performance , Exchange Traded Concepts , News Ratings For Replimune Group Daily , Replimune Group Inc , Institutional Investors Weigh In On Replimune Group , Free Report , Research Capital , Universal Asset Management , Traded Concepts , Chairman Philip Astley Sparke , Exchange Commission , Director Robert Coffin , Get Free Report , Replimune Group Daily ,

Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO

(RTTNews) - Biotechnology company Replimune Group, Inc. (REPL) announced Tuesday changes to its executive leadership team designed to support the . ....

Sushil Patel , Philip Astley Sparke , Replimune Group Inc , Replimune Group , Executive Chairman , Chief Commercial Officer , Chief Strategy ,

Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update

Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Philip Astley Sparke , Chris Brinzey , Arleen Goldenberg , Replimune Group Inc , Securities Exchange , International Society For Melanoma Research Congress On , Drug Administration , Society For Immunotherapy Of Cancer , Exchange Commission , Program Highlights Milestones , Reports Fiscal Third Quarter , Provides Corporate , Annual Meeting , Annual International Society , Melanoma Research Congress , Securities Act , Securities Exchange Act , Annual Reports , Quarterly Reports , Consolidated Statements , Months Ended December , Balance Sheet Data ,

Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference

28.12.2023 - WOBURN, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) - Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that Philip Astley-Sparke, Chief . ....

San Francisco , United States , Philip Astley Sparke , Francis Hotel , Replimune Group Inc , Chief Executive Officer , Healthcare Conference , Replimune Group Chart , Eplimune Group Kurs , Eplimune Group Aktie ,

RP1 Plus Cemiplimab Misses Response End Points in Locally Advanced or Metastatic CSCC

The combination of RP1 and cemiplimab provided a numerical, but not statistically significant, improvement in response rates vs cemiplimab alone in patients with locally advanced or metastatic cutaneous squamous cell carcinoma, missing the primary end points of the phase 2 CERPASS trial. ....

Philip Astley Sparke , Replimune Group Inc , Replimune Group , Combination Of Rp1 And Cemiplimab , Patients With Locally Advanced Or Metastatic Cutaneous Squamous Cell Carcinoma , Phase 2 Cerpass Trial ,